2024-04-01 14706868 2025-03-31 14706868 2024-04-01 2025-03-31 14706868 2024-03-31 14706868 2023-04-01 2024-03-31 14706868 uk-core:WithinOneYear 2024-03-31 14706868 uk-core:WithinOneYear 2025-03-31 14706868 uk-core:AfterOneYear 2024-03-31 14706868 uk-core:AfterOneYear 2025-03-31 14706868 uk-core:ShareCapital 2025-03-31 14706868 uk-core:ShareCapital 2024-03-31 14706868 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 14706868 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 14706868 uk-bus:Director1 2024-04-01 2025-03-31 14706868 uk-core:WithinOneYear 2025-03-31 14706868 uk-core:WithinOneYear 2024-03-31 iso4217:GBP xbrli:pure 14706868 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14706868 uk-bus:FRS102 2024-04-01 2025-03-31 14706868 uk-bus:FilletedAccounts 2024-04-01 2025-03-31 14706868 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31

Draft

Arca Biologistics Limited

Registered Number:14706868

For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements

2

Draft

For the year ended 31 March 2025
Arca Biologistics Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3

Draft

Registered Number :

14706868

As at 31 March 2025

Arca Biologistics Limited
Statement of Financial Position

£

£

2024
2025

Notes

Fixed assets

Property, plant and equipment

47,087
32,725
2
47,087
32,725

Current assets

Inventories

-
2,817
3

Trade and other receivables

12,859
42,298
4
4,770

Cash and cash equivalents

-
45,115
17,629

Trade and other payables: amounts falling due within one
year

(12,190)
(115,493)
5
5,439
(70,378)
Net current liabilities

Total assets less current liabilities

(23,291)
38,164

Trade and other payables: amounts falling due after more
than one year

(10,000)
-
6
(23,291)
Net assets/liabilities
28,164

Capital and reserves

Called up share capital

120,100
120,100

Retained earnings

(143,391)
(91,936)
(23,291)
28,164
Shareholders' funds

For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006

The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Mr Jamie Dickinson Director

These financial statements were approved and authorised for issue by the Board on 18 November 2025 and were signed by:

The notes form part of these financial statements

1 of 3
4

Draft

For the year ended 31 March 2025
Arca Biologistics Limited
Notes to the Financial Statements
Statutory Information

Arca Biologistics Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 14706868.

Registered address:

Cheshire House 164 Main Road
Goostrey
Crewe
England
CW4 8JP

The presentation currency is £ sterling.

1. Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1 A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.

2. Property, plant and equipment

Plant and
Machinery

£

Cost or
valuation

At 01 April 2024

38,500
22,671

Additions

At 31 March 2025

61,171

Provision for depreciation and impairment

At 01 April 2024

5,775
Charge for year
8,309

At 31 March 2025

14,084

At 31 March 2025

Net book value

47,087

At 31 March 2024

32,725

3. Inventories

2024
2025

£

£

Stocks

2,817
-

2 of 3
5

Draft

For the year ended 31 March 2025
Arca Biologistics Limited
Notes to the Financial Statements Continued

4. Trade and other receivables

2024
2025

£

£

Trade debtors

34,746
10,239

Other debtors

7,552
2,620
12,859
42,298

5. Trade and other payables: amounts falling due within one year

2024
2025

£

£

Bank loans and overdraft

3,836
-

Trade creditors

29,747
10,940

Amounts owed to group undertaking and undertaking in which the
company has a participating interest

20,000
-

Taxation and social security

2,411
-

Other creditors

59,499
1,250
115,493
12,190

6. Trade and other payables: amounts falling due after more than one year

2024
2025

£

£

Amounts owed to group undertaking and undertaking in which the
company has a participating interest

-
10,000

7. Average number of persons employed

During the year the average number of employees was 8 (2024 : 4)
3 of 3